Skip to main content

Table 2 Characteristics of the FXS NVIQ median-split subgroups

From: Auditory repetition suppression alterations in relation to cognitive functioning in fragile X syndrome: a combined EEG and machine learning approach

Variable

≤ 42 NVIQ group

> 42 NVIQ group

N

8 (0 female)

6 (4 female)

Age range

9–32 years

10–22 years

Mean age (SD)

16.38 (± 7.37)

14.34 (± 4.08)

NVIQ range

32–42

52–93

Mean NVIQ (SD)

38 (± 3.64)

62 (± 10.02)

Medication

N = 6

Methylphenidate (36–45 mg qd) (4)

Amphetamine mixed salts (50 mg qd) (1)

Venlafaxine (75 mg qd) (1)

N = 3

Methylphenidate (36–50 mg qd) (2)

Atomoxetine (25–40 mg qd) (2)

Citalopram (20 mg qd) (1)

Comorbidities

Autistic spectrum disorder (4)

Attention-deficit hyperactivity disorder (6)

Autistic spectrum disorders (1)

Attention deficit hyperactivity disorder (3)